 <h1>Belviq Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>lorcaserin</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about lorcaserin. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Belviq.</p><h2>In Summary</h2><p><b>Common side effects of Belviq include:</b> headache, hypoglycemia, decreased hemoglobin, euphoria, and lymphocytopenia. <b>Other side effects include:</b> constipation, dizziness, fatigue, increased serum prolactin, nausea, and xerostomia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to lorcaserin: oral tablet, oral tablet extended release</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, lorcaserin (the active ingredient contained in Belviq) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking lorcaserin:</p><p>
<i>More common</i>
</p><ul>
<li>Anxiety</li>
<li>bladder pain</li>
<li>bloody or cloudy urine</li>
<li>blurred vision</li>
<li>body aches or pain</li>
<li>chills</li>
<li>cold sweats</li>
<li>coma</li>
<li>confusion</li>
<li>cool, pale skin</li>
<li>cough</li>
<li>depression</li>
<li>difficult, burning, or painful urination</li>
<li>difficulty with breathing</li>
<li>dizziness</li>
<li>ear congestion</li>
<li>fast heartbeat</li>
<li>fever</li>
<li>frequent urge to urinate</li>
<li>headache</li>
<li>increased hunger</li>
<li>loss of voice</li>
<li>lower back or side pain</li>
<li>nasal congestion</li>
<li>nausea</li>
<li>nightmares</li>
<li>pounding in the ears</li>
<li>runny nose</li>
<li>seizures</li>
<li>shakiness</li>
<li>slow or fast heartbeat</li>
<li>slurred speech</li>
<li>sneezing</li>
<li>sore throat</li>
<li>swelling of the breasts or breast soreness in both females and males</li>
<li>unexpected or excess milk flow from the breasts</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>decreased ability to exercise</li>
<li>dry mouth</li>
<li>flushed, dry skin</li>
<li>fruit-like breath odor</li>
<li>increased hunger</li>
<li>increased sensitivity to sunlight</li>
<li>increased thirst</li>
<li>increased urination</li>
<li>itching, pain, redness, or swelling of the eye or eyelid</li>
<li>joint pain</li>
<li>loss of consciousness</li>
<li>rapid weight gain</li>
<li>severe skin rash or hives</li>
<li>stomachache</li>
<li>sweating</li>
<li>swollen glands</li>
<li>tingling of the hands or feet</li>
<li>trouble with breathing</li>
<li>trouble with sleeping</li>
<li>unexplained weight loss</li>
<li>unusual weight gain or loss</li>
<li>vomiting</li>
<li>watering of the eyes</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Black, tarry, stools</li>
<li>chest pain</li>
<li>cough or hoarseness</li>
<li>pale skin</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>swollen glands</li>
<li>unusual bleeding or bruising</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Agitation</li>
<li>confusion</li>
<li>convulsions</li>
<li>diarrhea</li>
<li>high fever</li>
<li>increased sweating</li>
<li>loss of bladder control</li>
<li>overactive reflexes</li>
<li>painful or prolonged erection of the penis</li>
<li>poor coordination</li>
<li>restlessness</li>
<li>severe muscle stiffness</li>
<li>shivering</li>
<li>talking or acting with excitement you cannot control</li>
<li>trembling or shaking</li>
<li>twitching</li>
<li>unusually pale skin</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking lorcaserin:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Abdominal or stomach discomfort</li>
<li>false or unusual sense of well-being</li>
<li>seeing, hearing, or feeling things that are not there</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of lorcaserin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Back pain</li>
<li>difficulty having a bowel movement (stool)</li>
<li>muscle aches</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Decreased appetite</li>
<li>difficulty with concentration</li>
<li>dry eyes</li>
<li>muscle spasms</li>
<li>muscle, joint, or bone pain</li>
<li>problems with memory</li>
<li>rash</li>
<li>sleeplessness</li>
<li>stress</li>
<li>toothache</li>
<li>trouble seeing</li>
</ul><p>
<!-- end oral tablet, oral tablet extended release --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to lorcaserin: oral tablet, oral tablet extended release</i></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 16.8%) </p>
<p><b>Common</b> (1% to 10%): Dizziness, impaired attention/memory</p>
<p><b>Uncommon</b> (0.1% to 1%): Tremor, confusion, disorientation</p>
<p><b>Very rare</b> (less than 0.01%): Serotonergic excess</p>
<p><b>Frequency not reported</b>: Neuroleptic Malignant Syndrome/serotonin syndrome, somnolence<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension</p>
<p><b>Uncommon</b> (0.1% to 1%): Regurgitant cardiac valvular heart disease, bradycardia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety, insomnia, stress, depression/mood problems</p>
<p><b>Uncommon</b> (0.1% to 1%): Euphoria, suicidal ideation</p>
<p><b>Frequency not reported</b>: Hallucination, dissociation<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Decreased lymphocyte count (up to 12.2%), decreased hemoglobin (up to 10.4%)</p>
<p><b>Common</b> (1% to 10%): Decreased red blood cell count, decreased neutrophil count</p>
<p><b>Uncommon</b> (0.1% to 1%): Decreased white blood cell count<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very common</b> (10% or more): Hypoglycemia (up to 29.3%)</p>
<p><b>Common</b> (1% to 10%): Worsening of diabetes mellitus, elevated prolactin<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (up to 13.7%), nasopharyngitis (up to 13%)</p>
<p><b>Common</b> (1% to 10%): Cough, oropharyngeal pain, sinus congestion<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, peripheral edema, chills<sup>[Ref]</sup></p><h3>General</h3><p>The most common adverse reactions for non-diabetic patients were headache, dizziness, fatigue, nausea, dry mouth, and constipation.  For diabetic patients, the most common adverse reactions were hypoglycemia, headache, back pain, cough, and fatigue.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p>
<p><b>Uncommon</b> (0.1% to 1%): Hyperhidrosis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, diarrhea, constipation, dry mouth, vomiting, toothache, gastroenteritis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Seasonal allergy<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back pain (up to 11.7%)</p>
<p><b>Common</b> (1% to 10%): Musculoskeletal pain, muscle spasms<sup>[Ref]</sup></p><h3>Ocular</h3><p>Non-diabetic patients experienced events of blurred vision, dry eye, and visual impairment.  Diabetic patients experienced visual disorders, conjunctival infections, irritations and inflammations, ocular sensation disorders, and cataract conditions.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Eye disorder<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Increased incidence of cancer<sup>[Ref]</sup></p><p>The U.S. Food and Drug Administration (FDA) reports that safety data from a lorcaserin clinical trial shows a possible increased risk of cancer.  In this trial of 12,000 participants over 5 years, more patients taking lorcaserin were diagnosed with cancer compared to patients taking placebo.  The cause of the cancer is uncertain, and it is unknown if this drug contributed to the cancer risk.  The FDA will continue to evaluate the clinical trial results and communicate final conclusions and recommendations once the review is complete.<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Belviq (lorcaserin)." Eisai Inc, Teaneck, NJ. </p><p id="ref_2">2. US Food and Drug Administration "Safety clinical trial shows possible increased risk of cancer with weightloss medicine Belviq, Belviq XR (lorcaserin) Available from: URL: https://www.fda.gov/media/134174/download."   ([2020, Jan 14]):</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Belviq (lorcaserin)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>927 Reviews</li>
<li>Drug class: anorexiants</li>
<li>FDA Alerts (2)</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Belviq &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Belviq XR</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Obesity</li>
<li>Weight Loss</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to lorcaserin: oral tablet, oral tablet extended release</i></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 16.8%) </p><p><b>Common</b> (1% to 10%): Dizziness, impaired attention/memory</p><p><b>Uncommon</b> (0.1% to 1%): Tremor, confusion, disorientation</p><p><b>Very rare</b> (less than 0.01%): Serotonergic excess</p><p><b>Frequency not reported</b>: Neuroleptic Malignant Syndrome/serotonin syndrome, somnolence<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension</p><p><b>Uncommon</b> (0.1% to 1%): Regurgitant cardiac valvular heart disease, bradycardia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety, insomnia, stress, depression/mood problems</p><p><b>Uncommon</b> (0.1% to 1%): Euphoria, suicidal ideation</p><p><b>Frequency not reported</b>: Hallucination, dissociation<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Decreased lymphocyte count (up to 12.2%), decreased hemoglobin (up to 10.4%)</p><p><b>Common</b> (1% to 10%): Decreased red blood cell count, decreased neutrophil count</p><p><b>Uncommon</b> (0.1% to 1%): Decreased white blood cell count<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very common</b> (10% or more): Hypoglycemia (up to 29.3%)</p><p><b>Common</b> (1% to 10%): Worsening of diabetes mellitus, elevated prolactin<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (up to 13.7%), nasopharyngitis (up to 13%)</p><p><b>Common</b> (1% to 10%): Cough, oropharyngeal pain, sinus congestion<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, peripheral edema, chills<sup>[Ref]</sup></p><h3>General</h3><p>The most common adverse reactions for non-diabetic patients were headache, dizziness, fatigue, nausea, dry mouth, and constipation.  For diabetic patients, the most common adverse reactions were hypoglycemia, headache, back pain, cough, and fatigue.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p><p><b>Uncommon</b> (0.1% to 1%): Hyperhidrosis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, diarrhea, constipation, dry mouth, vomiting, toothache, gastroenteritis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Seasonal allergy<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back pain (up to 11.7%)</p><p><b>Common</b> (1% to 10%): Musculoskeletal pain, muscle spasms<sup>[Ref]</sup></p><h3>Ocular</h3><p>Non-diabetic patients experienced events of blurred vision, dry eye, and visual impairment.  Diabetic patients experienced visual disorders, conjunctival infections, irritations and inflammations, ocular sensation disorders, and cataract conditions.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Eye disorder<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Increased incidence of cancer<sup>[Ref]</sup></p><p>The U.S. Food and Drug Administration (FDA) reports that safety data from a lorcaserin clinical trial shows a possible increased risk of cancer.  In this trial of 12,000 participants over 5 years, more patients taking lorcaserin were diagnosed with cancer compared to patients taking placebo.  The cause of the cancer is uncertain, and it is unknown if this drug contributed to the cancer risk.  The FDA will continue to evaluate the clinical trial results and communicate final conclusions and recommendations once the review is complete.<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Belviq (lorcaserin)." Eisai Inc, Teaneck, NJ. </p><p id="ref_2">2. US Food and Drug Administration "Safety clinical trial shows possible increased risk of cancer with weightloss medicine Belviq, Belviq XR (lorcaserin) Available from: URL: https://www.fda.gov/media/134174/download."   ([2020, Jan 14]):</p><h2>More about Belviq (lorcaserin)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>927 Reviews</li>
<li>Drug class: anorexiants</li>
<li>FDA Alerts (2)</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Belviq &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Obesity</li>
<li>Weight Loss</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>